Neoplasms: News and Research on Neoplasms, Connective Tissue

MeSH tree: C04.557.450.565

FDA approves Ogsiveo for desmoid tumors

The U.S. Food and Drug Administration has approved SpringWorks Therapeutics Inc.'s Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment.

page 7 from 10